VAERS_ID,RECVDATE,STATE,AGE_YRS,CAGE_YR,CAGE_MO,SEX,RPT_DATE,SYMPTOM_TEXT,DIED,DATEDIED,L_THREAT,ER_VISIT,HOSPITAL,HOSPDAYS,X_STAY,DISABLE,RECOVD,VAX_DATE,ONSET_DATE,NUMDAYS,LAB_DATA,V_ADMINBY,V_FUNDBY,OTHER_MEDS,CUR_ILL,HISTORY,PRIOR_VAX,SPLTTYPE,FORM_VERS,TODAYS_DATE,BIRTH_DEFECT,OFC_VISIT,ER_ED_VISIT,ALLERGIES
874013,6/22/2020,FR,5,nan,nan,U,nan,"Arthus reactionsemicolon redness at the injection sitesemicolon swelling at the injection sitesemicolon Initial information received on 16minusJunminus2020 regarding an unsolicited valid serious case received from a physician (medical doctor) via medical representative via email.  This case involves a five year old patient (gender not reported) who experienced redness at the injection site (vaccination site erythema), swelling at the injection site (vaccination site swelling) and was diagnosed with Arthus Reaction (Type III Immune Complex Mediated Reaction), when received INFLUENZA QUADRIVAL AminusB VACCINE [FLUQUADRI].  The patientquotes medical history, past medical treatments, vaccinations, concomitant medications and family history were not provided.  On 13minusJunminus2020, the patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVAL AminusB VACCINE (lot number and Expiry date not reported) via an intramuscular route in the left deltoid for prophylactic vaccination.  On 14minusJunminus2020, the patient developed redness at the injection site (vaccination site erythema), swelling at the injection site (vaccination site swelling) and was diagnosed with Arthus Reaction (Type III Immune Complex Mediated Reaction) one  day following the administration of INFLUENZA QUADRIVAL AminusB VACCINE. These  events were assessed as medically significant.  No laboratory data was provided.  Final diagnosis was Type III immune complex mediated reaction.  The patient was prescribed antiminusallergic medication as corrective treatment.  At the time of this report, patient was recovering from all the events.  There will be no information available on the lot number for this case.semicolon Senderquotes Commentscolon This case involves a five year old patient who experienced vaccination site erythema, vaccination site swelling and was diagnosed with Type III immune complex mediated reaction one day after vaccination with FLUQUADRI. The time to onset was compatible. However, patientquotes medical condition at time of vaccination and lab test ruling out alternate etiologies were not reported. Based upon the reported information the role of the suspect vaccine cannot be assessed.",nan,nan,nan,nan,nan,nan,nan,nan,N,6/13/2020,6/14/2020,1,nan,OTH,nan,nan,nan,nan,nan,THSA2020SA157011,2,6/22/2020,nan,nan,nan,nan
875102,7/6/2020,FR,nan,nan,nan,M,nan,"acute kidney injurysemicolon Renal impairmentsemicolon diabetes mellitussemicolon renal cystsemicolon lipase increasedsemicolon lymphocyte count decreasedsemicolon Neutrophil count increasedsemicolon red blood cell count decreasedsemicolon blood alkaline phosphatase increasedsemicolon blood chloride increasedsemicolon blood gases abnormalsemicolon blood urea increasedsemicolon Glomerular filtration rate decreasedsemicolon haematocrit decreasedsemicolon haemoglobin decreasedsemicolon Tubulointerstitial nephritissemicolon Nephritis allergicsemicolon Renal ischaemiasemicolon Dyspnoea exertionalsemicolon Fluid overloadsemicolon Rhinitissemicolon oedema peripheralsemicolon Viral infectionsemicolon acidosissemicolon Blood creatinine increasedsemicolon blood bicarbonate decreasedsemicolon heart rate increasedsemicolon hypersensitivitysemicolon influenza like illnesssemicolon lethargysemicolon chest discomfortsemicolon dehydrationsemicolon blood potassium increasedsemicolon Urinary tract infectionsemicolon Information has been received from the regulatory authority (AUminusTGAminus0000461447) on 22minusJUNminus2020.   This is a spontaneous case initially received from the pharmacist on 22minusMARminus2019, concerning an adult male patient (68minusyearminusold at the time of report). On 18minusMAYminus2009, the patient was administered Fluvax vaccine. The patientquotes historical condition included bladder cancer (reported as bladder CA). The patientquotes current conditions included hypertension (reported as medical history), chronic renal impairment (CRI) which was known to renal physician, decreased estimated glomerular filtration rate (EGFR) (30minus40) and baseline creatinine level of 200 (reported as medical history) and neominusbladder. The patientquotes current procedure included selfminuscatheterization. The patientquotes concomitant medications included candesartan (reported as candesarten) and gliclazide. On 17minusMAYminus2013, the patient was administered Fluvax (TIV) (influenza vaccine, dose, route of administration, anatomical location, batch number and expiry datecolon not reported) for an unknown indication. On an unspecified date, after vaccination, the patient experienced flare up of renal impairment. On 27minusMAYminus2015, the patient was administered nonminuscompany suspect vaccinesminus Fluarix (dose, route of administration, anatomical location, batch number and expiry datecolon not reported) and Pneumococcal vaccine, polyvalent (23minusvalent) (PNEUMOVAX23) 23 (dose, route of administration, anatomical location, batch number and expiry datecolon not reported) for unknown indications. On an unspecified date in July 2015, September 2015 and April 2016, the patient experienced recurrent episodes of urinary tract infection (UTI) respectively. The patient had chronic renal impairment due to recurrent episodes of UTI. On 02minusMAYminus2016, the patient was administered nonminuscompany suspect vaccineminus influenza virus split virion 4v vaccine inactivated (FLUARIX TETRA) (dose, route of administration, anatomical location, batch number and expiry datecolon not reported) for an unknown indication. On 10minusOctminus2016, the patient was administered nonminuscompany suspect vaccine diphtheria toxoid, pertussis acellular 3minuscomponent vaccine, tetanus toxoid (BOOSTRIX), (dose, route of administration, anatomical location, batch number and expiry datecolon not reported) for an unknown indication. On 06minusAPRminus2017, the patient was administered nonminuscompany suspect vaccine Zoster vaccine live (ZOSTAVAX), (dose, route of administration, anatomical location, batch number and expiry datecolon not reported) for an unknown indication. On 22minusMAYminus2017, the patient was administered nonminuscompany suspect vaccine influenza virus split virion 4v vaccine inactivated (FLUARIX TETRA) (dose, route of administration, anatomical location, batch number and expiry datecolon not reported) for an unknown indication. On an unspecified date in MAYminus2017, the patient experienced recurrent episode of urinary tract infection (UTI). On 08minusJUNminus2018, at the age of 68 years, the patient was administered nonminuscompany suspect vaccine Fluzone (dose, route of administration, anatomical location, batch number and expiry datecolon not reported) for an unknown indication.  On an unspecified date in 2018, the patient experienced flu like symptoms for 3/52 (as reported). On an unspecified date in June 2018, the patient experienced allergic type interstitial nephritis and was treated with prednisolone (wearing dose plan). The patient also experienced chronic glomerular ischemia. On an unspecified date in 2018, the patient experienced acute renal failure with the symptoms of worsening lethargy and shortness of breath on exertion. The patient also developed mild coryzal symptoms and since then, had a gradual worsening of symptoms (unspecified). The patient had no fevers and pain but had chest tightness. The patient was seen by the general practitioner (GP) and underwent blood test which demonstrated acute on chronic renal impairment and creatinine level was 673 (blood creatinine increased). The patient was alert, oriented and afebrile. The patientquotes other examinations included increased heart ratecolon 108, respiratory rate (RR)colon 18 at rest, tachypnoea with exertion, oxygen saturation ratecolon 98 percent (normal) (reported as SATS RA). The patientquotes chest examination included bilateral air entry S1 and S2, abdomen was soft and nonminustender and mild pitting oedema in the legs. The patientquotes electrocardiogram (ECG) included sinus rhythm (SR), mild tenting of T waves and there was no previous test to compare with. The patientquotes blood examination included PH of 7.4 (normal), creatininecolon 730 (increased), bicarbonate levels 6 (decreased) and potassium levelscolon 5.7 (increased). It was noted that, the patient had acute on chronic renal failure with acidosis and mild fluid overload and needed hemofiltration. The investigational plan included CT scan of renal (for imaging) and ICU referral for hemofiltration. On 21minusJULminus2018 at 00colon 05 hours, the patient was admitted to the hospital and was transferred to ICU. The suspected etiology of acute renal impairment included viral illness, dehydration and patient was on Atacand (candesartan). The patient had moderate allergic reactions. The patient had no documented reactions to morphine and reactions to Triprim (trimethoprim) was unknown.  On 21minusJULminus2018 at 1colon53 hours, the laboratory investigations in discharge report included, haemoglobincolon 104 g/L (low), white cell countcolon 11.4x 10E9/L (normal), platelet countcolon 287x10E9/L (normal), red blood cell countcolon 3.34x10E12/L (low), haematocritcolon 0.31 L/L (low), mean corpuscular volumecolon 92 femtolitre (FL) (normal), mean corpuscular haemoglobincolon 31.0 per gram (pg) (normal), mean cell haemoglobin concentrationcolon 338 g/L (normal), neutrophils absolutecolon 9.7x10E9/ L (high), lymphocyte absolutecolon 0.7x10E9/ L (low), monocytes absolutecolon 0.9x10E9/ L (normal), eosinophils absolutecolon 0.1x10E9/L (normal), basophils absolutecolon 0.0x10E9/L (normal). The patientquotes haematology report (FBE) included sodium levelcolon 139 mmol/L (normal), potassium levelcolon 5.7 mmol/ L (high), chloride levelcolon 111 mmol/ L (high), bicarbonate levelcolon 5 mmol/ L (low), urea levelcolon 47.0 mmol/ L (high), creatinine levelcolon 742 micromol/ L (high), eGFRcolon 6 (low), total bilirubincolon 2 micromol/ L (normal), alanine aminotransferasecolon 20 units/L (normal), gamma glutamyl transferasecolon 20 units/ L (normal), alkaline phosphatasecolon 204 units/L (high), protein totalcolon 71 g/L (normal), albumin levelcolon 39 g/L (normal), globulin levelcolon 32 g/L (normal), lipase levelcolon 173 units/ L (high). The patientquotes general chemistry report included blood gas fraction of inspired oxygen (FiO2)colon 21 percent (low). The sample type venous results included blood gas pHcolon 7.04 (low), blood gas partial pressure of oxygen (pO2)colon 42 mmHg (low), blood gas partial pressure of carbonminusdiminusoxide (pCO2)colon 24 mmHg (low), blood gas bicarbonatecolon 6 mmol/L (low), blood gas O2 saturationcolon 70 percent (low), blood gas sodiumcolon 138 mmol/ L (normal), blood gas potassiumcolon 5.54 mmol/L (normal), blood gas chloridecolon 117 mmol/L (high), blood gas calcium ionizedcolon 1.11 mmol/L (low), blood gas total haemoglobincolon 107 g/L (low), blood gas oxyhaemoglobincolon 69.3 percent (low), blood gas carboxyhaemoglobincolon 0.5 percent (normal), blood gas methaemoglobincolon 1.1 percent (normal), blood gas reduced haemoglobincolon 29.1 percent (high), blood gas total bilirubincolon 9 micromol/L (normal), blood gas blood glucosecolon 6.9 mmol/L (normal), blood gas lactatecolon 0.6 mmol/L (normal), blood gas base excesscolon 23.2 mmol/L (low), blood gas temperaturecolon 37.0 Celsius (normal).   On the same day, the patient was discharged from the hospital. The patientquotes discharged medications were not provided. On 12minusOCTminus2018, the patient developed right renal cyst. On 26minusOCTminus2018, the patient experienced diabetes. It was reported that on an unspecified date, the patient died (reported as deceased), which was unrelated to allergic reactions. The cause of death was unknown and autopsy reports was not provided. The outcome of the event interstitial nephritis was resolved, and outcome of other events was not reported. The reporter assessed the case as serious (death). This case (201902696) was linked to the casecolon 201902695 (same patient). Followminusup information received from pharmacist on 25minusMARminus2019colon Added date of birth and the age group of the patient in tab. The reporter also confirmed the vaccination date of the Fluzone vaccine (08minusJUNminus2018) and experienced flu like symptoms for 3/52 (as reported). It was reported that the patient was hospitalized on 21minusJULminus2018 and received prednisolone as treatment for allergic type interstitial nephritis. The narrative was amended accordingly. Nonminussignificant follow up retrieved from regulatory authority (regulatory authority Reference numbercolon AUminusTGAminus0000461447), reported to regulatory authority by pharmacist on 03minusAPRminus2019colon The regulatory authority reference number AUminusTGAminus0000461447 was added in the additional information tab. No changes were made in narrative. Follow up received from the pharmacist on 06minusMAYminus2019colon The patientquotes age at vaccination (63 years) were added in the patient tab. The patientquotes current condition ‘renal diseasequote was deleted in the patient tab. The patientquotes historical conditions (UTI, nephritis) and current condition (diabetes) were deleted from the patient tab and added as events in the event tab. The patientquotes current conditions (hypertension, chronic renal impairment (CRI), decreased estimated glomerular filtration rate (EGFR), baseline creatinine level of 200 and neominusbladder) were added in the patient tab. The patientquotes current condition bladder cancer was coded as historical condition in the patient tab. The patientquotes historical vaccine influenza virus split virion 4v vaccine inactivated (FLUARIX TETRA) was deleted and the historical vaccine Afluria Quad was recoded to Fluvax in the patient tab. The patientquotes current procedure (selfminuscatherterization) was added in the patient tab. The patientquotes lab investigations were added in the patient tab. patientquotes suspect vaccine Afluria Quadivalent was recoded to Fluax (TIV) in the product tab and listedness was done accordingly in the event assessment tab. The patientquotes cominussuspect vaccines (Pneumococcal vaccine, polyvalent (23minusvalent) (PNEUMOVAX23) 23, Zoster vaccine live (ZOSTAVAX), Fluarix, influenza virus split virion 4v vaccine inactivated (FLUARIX TETRA), diphtheria toxoid, pertussis acellular 3minuscomponent vaccine, tetanus toxoid (BOOSTRIX), and FLuzone) were added in the product tab. The patientquotes treatment medication (prednisolone) was added in the product tab. The patientquotes events (death, acute renal failure, nephritis interstitial, nephritis allergic, diabetes, renal ischemia, acidosis, fluid overload, recurrent UTI, flu like symptoms, viral infection, chest tightness, coryzal symptoms, dehydration, renal cyst, blood bicarbonate decreased, heart rate increased, potassium increased, hemoglobin decreased, hematocrit decreased, red blood cell count low, absolute neutrophil count increased, absolute lymphocyte count decreased, blood chloride increased, alkaline phosphatase increased, lipase increased, blood gases abnormal, allergic reaction, lethargy, exertional dyspnoea, pitting leg oedema, urea blood level increased, creatinine high and estimated glomerular filtration rate decreased) were added in the event tab. The narrative was amended accordingly.",nan,nan,nan,nan,nan,nan,nan,nan,Y,5/27/2015,7/1/2015,35,Test Datecolon 2018semicolon Test Namecolon oxygen saturationsemicolon Test Resultcolon  98 %,UNK,nan,candesartansemicolon gliclazide,nan,nan,nan,AU0095075132006AUS009140,2,7/2/2020,nan,nan,nan,nan
876031,7/14/2020,FR,46,46,nan,M,nan,"the patient had a significant weight losssemicolon he had a reaction of a malaise as if it were a ‘hangoverquotesemicolon dizzinesssemicolon a lot of allergic processsemicolon spots on his bodysemicolon nauseasemicolon feeling of weakness as if it were hangoversemicolon tirednesssemicolon shortness of breathsemicolon skin lesions (typical of an allergic process)semicolon a lot of painsemicolon a lot of malaise/ unwellsemicolon feeling that he would diesemicolon reddish rashsemicolon discomfortsemicolon This case was reported by a nurse via sales rep and described the occurrence of skin lesion in a 46minusyearminusold male patient who received HAB (Twinrix adult) (batch number AHABB382AN, expiry date unknown) for prophylaxis.   Cominussuspect products included DTPa (Reduced antigen) (Boostrix) (batch number AC37B313AB, expiry date unknown) for prophylaxis and Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2019minus2020 season) (batch number UJ373AB ?, expiry date unknown) for prophylaxis.   On 16th May 2020, the patient received the 1st dose of Twinrix adult, Boostrix and Influenza vaccine Quadrivalent 2019minus2020 season. On an unknown date, less than a month after receiving Twinrix adult, Boostrix and Influenza vaccine Quadrivalent 2019minus2020 season, the patient experienced skin lesion, pain, malaise, feeling abnormal and red rash. On an unknown date, the outcome of the skin lesion, pain, malaise, feeling abnormal and red rash were recovered/resolved.   It was unknown if the reporter considered the skin lesion, pain, malaise, feeling abnormal and red rash to be related to Twinrix adult, Boostrix and Influenza vaccine Quadrivalent 2019minus2020 season.  Additional details were reported as followscolon The age at vaccination was not reported. The patient received vaccines Twinrix, flu vaccine tetravalent and Boosterix on the same day. The patient informed that the vaccine (Hepatitis A and B), caused a very strong reaction, skin lesions (typical of an allergic process), a lot of pain, a lot of malaise, a feeling that he would die. However, the patient said that on the day of reporting he was better. The reporter also sent a photo of what appears to be the patientquotes forearm with reddish rashes.  The patientquotes leg also appears in the photo, in addition to the forearm but it was normal.  It was not mentioned in the report whether the picture was taken after the first or second administration. No other information was provided. The reporter consented to follow up. For tolerance of 2nd dose to Twinrix refer case, BR2020AMR110358.    Followminusup information received from nurse on 30th June 2020colon The patientquotes sister contacted the clinic on the date of reporting and said that the patient was unwell and they are waiting for a position. As per followup of 1st July 2020, the first administration of the vaccine was with coadministration of the vaccines DTPa and tetravalent flu vaccine, however in the return for administration of the second dose of Twinrix, no vaccine was cominusadministered and the patient had the same reactions. The reporter reported that one day before date of reporting a patientquotes family member contacted her informing that the patient had a significant weight loss, that he had a feeling of discomfort and dizziness, as if it were a hangover and that he was demanding positioning from the clinic. Less than a month after receiving the vaccine the patient had weightloss, discomfort, dizziness and hangover. No other information was provided. It was unknown if the reporter considered the weight loss, hangover, dizziness and discomfort to be related to Twinrix adult, Boostrix and tetravalent flu vaccine.   Followminusup information received from nurse on 7th July 2020colon The patientquotes demographic details were updated. The suspect Influenza vaccine Quadrivalent 2019minus2020 season, updated to Influenza vaccine Quadrivalent 2020minus2021 season. The reporter stated that last week from the reporting date, a report was made informing that the patient was having a lot of allergic process, spots on his body, dizziness, nausea, feeling of weakness as if it were hangover.  The patientquotes relative made a new contact and informed that last sunday from the reporting date, patient was admitted at the hospital and underwent several tests, such as blood count and tomography. The patient also attended several medical appointments, upon tomography, a doctor said that the reaction was due to the vaccine.  The reporter believed that the patient had some other disease and wanted to blame the vaccine, as she was not the one who attended the relative, she informed a new email for us to speak with the person in charge. The reporter consented to follow up, if any other contact attempt was needed. All information available were obtained. The reporter confirmed that the DTPAminusR and Tetravalente flu vaccines were administered on 16th May 2020, together with the 1st dose of the Hepatitis A+B vaccine. The reporter stated that after the 1st dose, patient had already reported a malaise and allergic process. According to patient and his family, events increasedcolon weight loss, weakness, tiredness, shortness of breath, among other symptoms. The events had not resolved till the time of reporting. The symptoms started on the 1st day after the 1st dose was administered. The reporter was precisely in doubt about event associated with the use of the medication or not. The patientquotes family was very worried, investigated symptoms, with medical help. It was unknown if patient used any concomitant medication or had any relevant medical history. The reporter considered the weight loss, hangover, dizziness, allergy, skin staining, nausea, weakness, tiredness, shortness of breath, skin lesion, pain, malaise, feeling abnormal, red rash and discomfort to be related to Twinrix adult, Boostrix and Influenza vaccine Quadrivalent 2020minus2021 season. The patient was under medical care at the time of reporting because his health condition had became much worse.  The reporter asked for urgency in this return, because the clinic (vaccination clinic) did not know what to do anymore. No other information was provided.semicolon Senderquotes Commentscolon  BRminusGLAXOSMITHKLINEminusBR2020AMR110358colonSame reporter",nan,nan,nan,nan,Y,nan,nan,nan,N,5/16/2020,5/17/2020,1,"Test Datecolon 20200705semicolon Test Namecolon blood countsemicolon Result Unstructured Datacolon (Test Resultcolonresult value not provided,Unitcolonunknown)semicolon Test Datecolon 20200705semicolon Test Namecolon lab testsemicolon Result Unstructured Datacolon (Test ResultcolonTomography result not provided,Unitcolonunknown)",UNK,nan,nan,nan,nan,nan,BRGLAXOSMITHKLINEBR2020AM,2,7/14/2020,nan,Y,nan,nan
